Key highlights from Camlin Fine Sciences Q3FY23 concall:
โน 140
Like and Retweet for Maximum Reach!
โน 140
Like and Retweet for Maximum Reach!
1. The company has successfully commissioned its 6000 MTPA vanillin plant at Dahej on 22 January 2023 and has attained 50% capacity utilisation . The samples have been sent to the companyโs customers and the company has received a satisfactory response for this product.
The company expects to begin commercial supplies by Q1FY24.
2. The company right now has 20% of the global vanillin capacity with the major competition being Solvay.
2. The company right now has 20% of the global vanillin capacity with the major competition being Solvay.
The target market for Vanillin is the US and Europe and both Solvay and CFS are preferred suppliers for these markets as both of them are backward integrated till the basic raw material Catechol and can produce vanillin using environment friendly technologies.
3. The vanillin market is growing at a CAGR of 4% and there is no new supply for Vanillin
The company will start getting benefits from their vanillin plant by FY24.
The company will start getting benefits from their vanillin plant by FY24.
The company is not planning any large capex as of now and plans to do the maintenance capex of Rs 20-25 crore purely by internal accruals.
4. The company has got the first commercial order from Lockheed Martin for supply of a specialty chemical which will be used in the batteries made by Lockheed. The company is on track of supplying this product and plans to conclude the supply by Q1FY24.
The company is expecting subsequent orders towards the end of FY24. If the battery gets a good response in the market, there is a chance that the company may get more than 10% of business from Lockheed Martin going forward.
Loading suggestions...